t-cells

Documents about t-cells

• Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment#914818ClinicalTrials.gov
• Donor Regulatory T Cells in Treating Patients With Visceral Acute Graft-versus-Host Disease After Stem Cell Transplant#918479ClinicalTrials.gov
• Fate of hepatitis D virus-specific CD8+ T cells during bulevirtide monotherapy in patients with chronic hepatitis delta#1015163Deutsche Nationalbibliothek
• Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation#1032124ClinicalTrials.gov
• To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALL#824946ClinicalTrials.gov
• Phase 2 Study of Rapcabtagene Autoleucel in Myositis#827901ClinicalTrials.gov
• Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia#801882ClinicalTrials.gov
• R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors#908775ClinicalTrials.gov
• T cell receptor repertoires associated with control and disease progression following mycobacterium tuberculosis infection#228772SUNScholar
• A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer#828228ClinicalTrials.gov
• Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML#889362ClinicalTrials.gov
• Contrasting roles for IKK-regulated inflammatory signalling pathways for development and maintenance of type 1 and adaptive γδ T cells.#981NCBI PubMed Central
• Increased reluctant vesicles underlie synaptic depression by GPR55 in axon terminals of rat cerebellar Purkinje cells#5509Europe PMC
• Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory Acute B Lymphocytic Leukemia#28330ClinicalTrials.gov
• Highly activated CD4+ T regulatory cells associated with non- responders to immune-checkpoint inhibitors in metastatic melanoma#130420Unpaywall
• Synergistic Antitumor Efficacy of Radiofrequency Ablation Combined With TROP2-CAR-T Cells in a Xenograft Mouse Model of Lung Adenocarcinoma.#157031NCBI PubMed Central
• Immunotherapy of Natural Killer(NK) Cells in Human T Lymphotropic Virus Type 1(HTLV-1) Associated Myelopathy(HAM)#162473ClinicalTrials.gov
• A whole blood intracellular cytokine assay optimised for field site studies demonstrates polyfunctionality of CD4+ T cells in acute scrub typhus#211644Ora Oxford University Research
• Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells#226260ClinicalTrials.gov
• Investigating the Immune Response to Glioblastoma in Unique Central Nervous System Niches#273835Harvard DASH
• Matched Sibling Allogenic Stem Cell Transplantation With Adoptive Immunotherapy With Regulatory And Conventional T Cells For High Risk Acute Myeloid Leukemia#303749ClinicalTrials.gov
• Breaking the resistance barrier: synergistic evolution of CAR-T cells and bispecific antibodies in the era of precision immuno-oncology.#371522NCBI PubMed Central
• Breast Cancer Cell-Derived Exosomal miR-92b-3p Promotes Tumor Angiogenesis and Metastasis by Suppressing PTEN in Vascular Endothelial Cells.#402821NCBI PubMed Central
• Regulatory T cells in perioperative neurocognitive disorders: a systematic review with structured narrative synthesis from molecular mechanisms to clinical translation.#418424NCBI PubMed Central
• Reconstitution and Licensing of Natural Killer Cells Following T-Cell Replete Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide and Antithymocyte Globulin#475987HAL (France)
• Notch2 signaling instructs viral and bacterial TLR responsiveness in B cells#484997Europe PMC
• Elranatamab: A novel B-cell maturation T-cell engager#642684Europe PMC
• Low-dose Interleukin-2 in Women With Unexplained Miscarriages#834604ClinicalTrials.gov
• ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma#870827ClinicalTrials.gov
• Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation#885644ClinicalTrials.gov
• Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands#888073ClinicalTrials.gov
• Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma#899187ClinicalTrials.gov
• Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV#907865ClinicalTrials.gov
• Safety and Efficacy of IM21 Car-t Cells in Patients With Recurrent or Refractory BCMA Positive Multiple Myeloma#967446ClinicalTrials.gov
• CARv3-TEAM-E T Cells in Glioblastoma#1010456ClinicalTrials.gov
• Clinical Trial of SL1904B CAR-T Cells for Relapsed or Refractory Non-Hodgkin Lymphoma#1031381ClinicalTrials.gov
• Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma#230466ClinicalTrials.gov
• Figure 1 from CD4⁺ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy#246353Figshare
• Figure 2 from CD4⁺ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy#246354Figshare
• Figure 3 from CD4⁺ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy#246355Figshare
• Figure 4 from CD4⁺ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy#246356Figshare
• Figure 5 from CD4⁺ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy#246357Figshare
• Figure 6 from CD4⁺ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy#246358Figshare
• The clinical picture of ICANS after CAR-T cell therapy in critically ill patients: A retrospective clustering analysis of a multicentre multinational cohort study#669977HAL (France)
• Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)#835765ClinicalTrials.gov
• Autologous Natural Killer T Cells Infusion for the Treatment of Cancer#28337ClinicalTrials.gov
• ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma#152518ClinicalTrials.gov
• Precise Alternation Between Image-Forming Sample Planes Enables Quantitative Monitoring of Receptor-Arrestin Interaction Dynamics at the Plasma Membrane of Live Cells#192341bioRxiv / medRxiv
• Serum sCD25 predicts mortality and reflects IL-2-driven dysregulation of CD4⁺CD25⁺ T cells in severe fever with thrombocytopenia syndrome.#214018NCBI PubMed Central
• THE INNATE CYTOKINE IL-18 INHIBITS CNS AUTOIMMUNITY THROUGH PREFERENTIAL ACTIVATION OF PROTECTIVE CD8 T-CELLS#263687ScholarlyCommons at Penn